Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta‐analysis

Abstract

Chinese herbal medicine (CHM) is gaining popularity in treating irritable bowel syndrome (IBS). Although its efficacy was shown in recent randomized controlled trials (RCTs), it is rarely compared with antispasmodics to confirm its effectiveness. We aimed to resolve this uncertainty through a network meta‐analysis.